BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23093376)

  • 1. Induction and inhibition of crystallization in drug-in-adhesive-type transdermal patches.
    Jain P; Banga AK
    Pharm Res; 2013 Feb; 30(2):562-71. PubMed ID: 23093376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and optimization of desogestrel transdermal contraceptive patch using crystallization studies.
    Sachdeva V; Bai Y; Kydonieus A; Banga AK
    Int J Pharm; 2013 Jan; 441(1-2):9-18. PubMed ID: 23262424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of crystallization in drug-in-adhesive-type transdermal patches.
    Jain P; Banga AK
    Int J Pharm; 2010 Jul; 394(1-2):68-74. PubMed ID: 20438819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel.
    Schulz M; Fussnegger B; Bodmeier R
    Eur J Pharm Biopharm; 2011 Feb; 77(2):240-8. PubMed ID: 21129483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation optimization of a drug in adhesive transdermal analgesic patch.
    Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation optimization of a drug in adhesive transdermal analgesic patch.
    Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
    Drug Dev Ind Pharm; 2016 Jun; 42(6):862-870. PubMed ID: 26227813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and use of crystallization inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids.
    Lipp R
    J Pharm Pharmacol; 1998 Dec; 50(12):1343-9. PubMed ID: 10052847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.
    Tang J; Bao J; Shi X; Sheng X; Su W
    J Microencapsul; 2018 Aug; 35(5):454-466. PubMed ID: 30229692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing and characterizing of tramadol hydrochloride transdermal patches prepared with Ficus carica fruit mucilage and povidone.
    Ahad HA; Ishaq BM; Shaik M; Bandagisa F
    Pak J Pharm Sci; 2016 May; 29(3):945-51. PubMed ID: 27166538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethinylestradiol and levonorgestrel preparations on the Belgian market: a comparative study.
    Vanheusden V; De Braekeleer K; Corthout J
    J Pharm Belg; 2012 Mar; (1):22-7. PubMed ID: 22536680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisolvent precipitation of novel xylitol-additive crystals to engineer tablets with improved pharmaceutical performance.
    Kaialy W; Maniruzzaman M; Shojaee S; Nokhodchi A
    Int J Pharm; 2014 Dec; 477(1-2):282-93. PubMed ID: 25447824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug release and adhesive properties of crospovidone-containing matrix patches based on polyisobutene and acrylic adhesives.
    Schulz M; Fussnegger B; Bodmeier R
    Eur J Pharm Sci; 2010 Dec; 41(5):675-84. PubMed ID: 20883778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adhesive layer thickness and drug loading on estradiol crystallization in a transdermal drug delivery system.
    Imani M; Lahooti-Fard F; Taghizadeh SM; Takrousta M
    AAPS PharmSciTech; 2010 Sep; 11(3):1268-75. PubMed ID: 20706877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems.
    Albarahmieh E; Qi S; Craig DQM
    Int J Pharm; 2016 Nov; 514(1):270-281. PubMed ID: 27863672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
    Arora P; Mukherjee B
    J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug crystallization - implications for topical and transdermal delivery.
    Hadgraft J; Lane ME
    Expert Opin Drug Deliv; 2016 Jun; 13(6):817-30. PubMed ID: 26766744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a Drug-in-Adhesive Transdermal Patch for Risperidone: Effect of Drug-Additive Interactions on the Crystallization Inhibition and In Vitro/In Vivo Correlation Study.
    Weng W; Quan P; Liu C; Zhao H; Fang L
    J Pharm Sci; 2016 Oct; 105(10):3153-3161. PubMed ID: 27522527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
    Desai D; Kothari S; Huang M
    Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems.
    Chen S; Singh J
    Pharm Dev Technol; 2005; 10(2):319-25. PubMed ID: 15926681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.